CH634986A5 - Cosmetic light-stabilising agent for the UV-A region - Google Patents
Cosmetic light-stabilising agent for the UV-A region Download PDFInfo
- Publication number
- CH634986A5 CH634986A5 CH688978A CH688978A CH634986A5 CH 634986 A5 CH634986 A5 CH 634986A5 CH 688978 A CH688978 A CH 688978A CH 688978 A CH688978 A CH 688978A CH 634986 A5 CH634986 A5 CH 634986A5
- Authority
- CH
- Switzerland
- Prior art keywords
- cyclopentanone
- cyclohexanone
- bis
- ester
- cosmetic
- Prior art date
Links
- 239000004611 light stabiliser Substances 0.000 title claims description 15
- 239000002537 cosmetic Substances 0.000 title claims description 14
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 claims description 37
- JHIVVAPYMSGYDF-PTQBSOBMSA-N cyclohexanone Chemical class O=[13C]1CCCCC1 JHIVVAPYMSGYDF-PTQBSOBMSA-N 0.000 claims description 17
- -1 methylenedioxy group Chemical group 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000005840 aryl radicals Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 150000003997 cyclic ketones Chemical class 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000000475 sunscreen effect Effects 0.000 description 8
- 239000000516 sunscreening agent Substances 0.000 description 8
- 150000003934 aromatic aldehydes Chemical class 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 4
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- CVTOCKKPVXJIJK-HBKJEHTGSA-N (2e,5e)-2,5-dibenzylidenecyclopentan-1-one Chemical compound O=C1\C(=C\C=2C=CC=CC=2)CC\C1=C/C1=CC=CC=C1 CVTOCKKPVXJIJK-HBKJEHTGSA-N 0.000 description 3
- NCHAALDGNRJQFO-UHFFFAOYSA-N 2,6-bis[(2,3-dimethoxyphenyl)methylidene]cyclohexan-1-one Chemical compound COC1=CC=CC(C=C2C(C(=CC=3C(=C(OC)C=CC=3)OC)CCC2)=O)=C1OC NCHAALDGNRJQFO-UHFFFAOYSA-N 0.000 description 3
- ZYMUNTZVOUBQAI-UHFFFAOYSA-N 2,6-bis[(4-methoxyphenyl)methylidene]cyclohexan-1-one Chemical compound C1=CC(OC)=CC=C1C=C(CCC1)C(=O)C1=CC1=CC=C(OC)C=C1 ZYMUNTZVOUBQAI-UHFFFAOYSA-N 0.000 description 3
- UQFVAGXCGYNBRC-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methylidene]cyclopentan-1-one Chemical compound COC1=CC=CC=C1C=C1C(=O)CCC1 UQFVAGXCGYNBRC-UHFFFAOYSA-N 0.000 description 3
- WTMNGZHQLCKKGP-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methylidene]cyclopentan-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C=C1C(=O)CCC1 WTMNGZHQLCKKGP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QMOAOGJBIBSQOO-AWKIKHLOSA-N (2e,5e)-2,5-bis[(e)-3-phenylprop-2-enylidene]cyclopentan-1-one Chemical compound O=C1\C(=C\C=C\C=2C=CC=CC=2)CC\C1=C/C=C/C1=CC=CC=C1 QMOAOGJBIBSQOO-AWKIKHLOSA-N 0.000 description 2
- CTKKGXDAWIAYSA-JSAVKQRWSA-N (2e,6e)-2,6-dibenzylidenecyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC=CC=2)CCC\C1=C/C1=CC=CC=C1 CTKKGXDAWIAYSA-JSAVKQRWSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- JIVGSHFYXPRRSZ-UHFFFAOYSA-N 2,3-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OC JIVGSHFYXPRRSZ-UHFFFAOYSA-N 0.000 description 2
- LNKNETAYXQLOBY-UHFFFAOYSA-N 2,5-bis(1,3-benzodioxol-5-ylmethylidene)cyclopentan-1-one Chemical compound C1=C2OCOC2=CC(C=C2C(C(CC2)=CC=2C=C3OCOC3=CC=2)=O)=C1 LNKNETAYXQLOBY-UHFFFAOYSA-N 0.000 description 2
- SWXUQQKBZLHYOF-UHFFFAOYSA-N 2,5-bis[(2-hydroxyphenyl)methylidene]cyclopentan-1-one Chemical compound OC1=CC=CC=C1C=C(CC1)C(=O)C1=CC1=CC=CC=C1O SWXUQQKBZLHYOF-UHFFFAOYSA-N 0.000 description 2
- NZSRSKNDCCSSGY-UHFFFAOYSA-N 2,5-bis[(4-hydroxy-3-methoxyphenyl)methylidene]-1-cyclopentanone Chemical compound C1=C(O)C(OC)=CC(C=C2C(C(=CC=3C=C(OC)C(O)=CC=3)CC2)=O)=C1 NZSRSKNDCCSSGY-UHFFFAOYSA-N 0.000 description 2
- DWPJEPVQLUJRMB-UHFFFAOYSA-N 2,5-bis[(4-methoxyphenyl)methylidene]cyclopentan-1-one Chemical compound C1=CC(OC)=CC=C1C=C(CC1)C(=O)C1=CC1=CC=C(OC)C=C1 DWPJEPVQLUJRMB-UHFFFAOYSA-N 0.000 description 2
- OANJLTUPMGCUCW-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methylidene]cyclohexan-1-one Chemical compound COC1=CC=CC=C1C=C1C(=O)CCCC1 OANJLTUPMGCUCW-UHFFFAOYSA-N 0.000 description 2
- YWWIHHSFVKZDAO-UHFFFAOYSA-N 2-[[4-(dimethylamino)phenyl]methylidene]-1-cyclohexanone Chemical compound C1=CC(N(C)C)=CC=C1C=C1C(=O)CCCC1 YWWIHHSFVKZDAO-UHFFFAOYSA-N 0.000 description 2
- BTSXEIQFVFMZLH-UHFFFAOYSA-N 2-[[4-(dimethylamino)phenyl]methylidene]cyclopentan-1-one Chemical compound C1=CC(N(C)C)=CC=C1C=C1C(=O)CCC1 BTSXEIQFVFMZLH-UHFFFAOYSA-N 0.000 description 2
- 239000004808 2-ethylhexylester Substances 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- VCDPHYIZVFJQCD-ZRDIBKRKSA-N (2e)-2-benzylidenecyclohexan-1-one Chemical compound O=C1CCCC\C1=C/C1=CC=CC=C1 VCDPHYIZVFJQCD-ZRDIBKRKSA-N 0.000 description 1
- ZFJFROHCPHULKY-PKNBQFBNSA-N (2e)-2-benzylidenecyclopentan-1-one Chemical compound O=C1CCC\C1=C/C1=CC=CC=C1 ZFJFROHCPHULKY-PKNBQFBNSA-N 0.000 description 1
- NADUQCROZYTGPH-UHFFFAOYSA-N 2,5-bis[(3,4-dimethoxyphenyl)methylidene]-1-cyclopentanone Chemical compound C1=C(OC)C(OC)=CC=C1C=C(CC1)C(=O)C1=CC1=CC=C(OC)C(OC)=C1 NADUQCROZYTGPH-UHFFFAOYSA-N 0.000 description 1
- YSEMBYWAAKOCKW-UHFFFAOYSA-N 2,5-bis[(4-hydroxyphenyl)methylidene]cyclopentan-1-one Chemical compound C1=CC(O)=CC=C1C=C(CC1)C(=O)C1=CC1=CC=C(O)C=C1 YSEMBYWAAKOCKW-UHFFFAOYSA-N 0.000 description 1
- YOTDZZKBJHGVNA-UHFFFAOYSA-N 2,6-bis[(3,4-dimethoxyphenyl)methylidene]cyclohexan-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C=C(CCC1)C(=O)C1=CC1=CC=C(OC)C(OC)=C1 YOTDZZKBJHGVNA-UHFFFAOYSA-N 0.000 description 1
- AKSHKVRCEXTHAZ-UHFFFAOYSA-N 2,6-bis[(4-aminophenyl)methylidene]cyclohexan-1-one Chemical compound C1=CC(N)=CC=C1C=C(CCC1)C(=O)C1=CC1=CC=C(N)C=C1 AKSHKVRCEXTHAZ-UHFFFAOYSA-N 0.000 description 1
- GHCRTWFKGXOMGI-UHFFFAOYSA-N 2,6-bis[[4-(2-methylpropyl)phenyl]methylidene]cyclohexan-1-one Chemical compound C(C(C)C)C1=CC=C(C=C2C(C(CCC2)=CC2=CC=C(C=C2)CC(C)C)=O)C=C1 GHCRTWFKGXOMGI-UHFFFAOYSA-N 0.000 description 1
- XRJCFZUOXQVWGF-UHFFFAOYSA-N 2,6-bis[[4-(dimethylamino)phenyl]methylidene]cyclohexan-1-one Chemical compound C1=CC(N(C)C)=CC=C1C=C(CCC1)C(=O)C1=CC1=CC=C(N(C)C)C=C1 XRJCFZUOXQVWGF-UHFFFAOYSA-N 0.000 description 1
- WHCQZGQBYXSTGD-UHFFFAOYSA-N 2,6-bis[[4-(ethylamino)phenyl]methylidene]cyclohexan-1-one Chemical compound C(C)NC1=CC=C(C=C2C(C(CCC2)=CC2=CC=C(C=C2)NCC)=O)C=C1 WHCQZGQBYXSTGD-UHFFFAOYSA-N 0.000 description 1
- CTKKGXDAWIAYSA-UHFFFAOYSA-N 2,6-dibenzylidenecyclohexan-1-one Chemical compound O=C1C(=CC=2C=CC=CC=2)CCCC1=CC1=CC=CC=C1 CTKKGXDAWIAYSA-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- AMTRLYKLKVRBSU-UHFFFAOYSA-N 2-[(3,4-dibutylphenyl)methylidene]cyclohexan-1-one Chemical compound C(CCC)C=1C=C(C=C2C(CCCC2)=O)C=CC=1CCCC AMTRLYKLKVRBSU-UHFFFAOYSA-N 0.000 description 1
- FLTPMKGSZHZVQN-UHFFFAOYSA-N 2-[(3,4-dichlorophenyl)methylidene]cyclohexan-1-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C=C1C(=O)CCCC1 FLTPMKGSZHZVQN-UHFFFAOYSA-N 0.000 description 1
- PSSVJCUFELEIPO-UHFFFAOYSA-N 2-[(3-hydroxyphenyl)methylidene]cyclopentan-1-one Chemical compound OC=1C=C(C=C2C(CCC2)=O)C=CC=1 PSSVJCUFELEIPO-UHFFFAOYSA-N 0.000 description 1
- CIYMWOQEOFSMQN-UHFFFAOYSA-N 2-[(4-aminophenyl)methylidene]cyclopentan-1-one Chemical compound NC1=CC=C(C=C2C(CCC2)=O)C=C1 CIYMWOQEOFSMQN-UHFFFAOYSA-N 0.000 description 1
- VTVVPTRDNLXHFT-UHFFFAOYSA-N 2-[(4-chlorophenyl)methylidene]cyclohexan-1-one Chemical compound C1=CC(Cl)=CC=C1C=C1C(=O)CCCC1 VTVVPTRDNLXHFT-UHFFFAOYSA-N 0.000 description 1
- WUMOJUUCPXEEQL-UHFFFAOYSA-N 2-[(4-chlorophenyl)methylidene]cyclopentan-1-one Chemical compound C1=CC(Cl)=CC=C1C=C1C(=O)CCC1 WUMOJUUCPXEEQL-UHFFFAOYSA-N 0.000 description 1
- BVBDQUGWHKRZSJ-UHFFFAOYSA-N 2-[(4-hydroxyphenyl)methylidene]cyclohexan-1-one Chemical compound C1=CC(O)=CC=C1C=C1C(=O)CCCC1 BVBDQUGWHKRZSJ-UHFFFAOYSA-N 0.000 description 1
- SBHXDCZQSURIGB-UHFFFAOYSA-N 2-[(4-hydroxyphenyl)methylidene]cyclopentan-1-one Chemical compound C1=CC(O)=CC=C1C=C1C(=O)CCC1 SBHXDCZQSURIGB-UHFFFAOYSA-N 0.000 description 1
- WHSMSOGFODOCIR-UHFFFAOYSA-N 2-[(4-methylphenyl)methylidene]cyclopentan-1-one Chemical compound C1=CC(C)=CC=C1C=C1C(=O)CCC1 WHSMSOGFODOCIR-UHFFFAOYSA-N 0.000 description 1
- ACCWCWKIASBEKV-UHFFFAOYSA-N 3-benzylideneheptan-2-one Chemical compound CCCCC(C(C)=O)=CC1=CC=CC=C1 ACCWCWKIASBEKV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
- OTNIKUTWXUODJZ-UHFFFAOYSA-N 7-(ethylamino)-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=CC(NCC)=CC=C21 OTNIKUTWXUODJZ-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000762 chronic effect Toxicity 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- DHKKONBXGAAFTB-UHFFFAOYSA-N cyclovalone Chemical compound C1=C(O)C(OC)=CC(C=C2C(C(=CC=3C=C(OC)C(O)=CC=3)CCC2)=O)=C1 DHKKONBXGAAFTB-UHFFFAOYSA-N 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- XPKFLEVLLPKCIW-UHFFFAOYSA-N ethyl 4-(diethylamino)benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC)CC)C=C1 XPKFLEVLLPKCIW-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HBDHXDBPCVDGQN-FPLPWBNLSA-N propan-2-yl (z)-tetradec-9-enoate Chemical compound CCCC\C=C/CCCCCCCC(=O)OC(C)C HBDHXDBPCVDGQN-FPLPWBNLSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
Gegenstand der Erfindung ist ein kosmetisches Lichtschutzmittel für den UV-A-Bereich mit einem Gehalt an Cyclopentanon- bzw. Cyclohexanonderivaten, die bei topischer Anwendung auf der Haut einen Schutz vor den schädigenden Einflüssen des längerwelligen UV-A-Anteils des Sonnenlichts bei längerer Einwirkung gewähren. The invention relates to a cosmetic light stabilizer for the UV-A range with a content of cyclopentanone or cyclohexanone derivatives which, when applied topically to the skin, provide protection against the damaging effects of the longer-wave UV-A component of sunlight when exposed to prolonged exposure .
Die allgemein als kosmetische Sonnenschutzmittel bzw. Lichtschutzmittel benutzten Präparationen enthalten zur Verhinderung des Sonnenbrandes Bestandteile, die den kurzwelligen UV-B-Anteil des Sonnenlichts absorbieren bzw. reflektieren. Sie setzen die Dosis an kurzwelliger Strahlung, die die äusseren Schichten der Haut durchdringt, herab und verhindern damit die Ausbildung schwerer Erytheme, ohne dass die durch den längerwelligen Anteil verursachte Bräunung unterbunden wird. Dieser längerwellige Anteil des Sonnenlichts, der den Bereich von 320-400 nm umfasst, ermöglicht aber nicht nur die angenehme Bräunung der Haut, sondern wird auch für die chronisch lichtgeschädigte Haut verantwortlich gemacht. Diese Schädigungen wurden früher als altersbedingt angesehen, man sprach allgemein von der The preparations generally used as cosmetic sunscreens or light stabilizers contain components which prevent or reflect the short-wave UV-B component of sunlight to prevent sunburn. They reduce the dose of short-wave radiation that penetrates the outer layers of the skin and thus prevent the development of severe erythema without preventing the tanning caused by the longer-wave portion. This longer-wave portion of sunlight, which covers the range of 320-400 nm, not only enables pleasant tanning of the skin, but is also held responsible for the chronically damaged skin. This damage was formerly considered age-related, it was generally referred to as
30 Altershaut. Heute weiss man jedoch, dass sie im wesentlichen von der Gesamtdauer und Stärke der Lichteinwirkung abhängen. Derartige Hautschädigungen machen sich durch eine erhöhte Faltenbildung der Haut infolge Elastizitätsverlust, durch eine Verdünnung der Oberhaut, eine Gelbbraun-35 färbung der Gesichtshaut, Pigmentverschiebungen und schliesslich durch Keratosen bemerkbar, die zu Krebsvorstufen und Hautkrebserkrankungen, wie Spinaliomen und Basaliomen, führen können. 30 aging skin. Today, however, it is known that they essentially depend on the total duration and intensity of the exposure to light. Such damage to the skin is manifested by increased wrinkling of the skin due to loss of elasticity, thinning of the epidermis, yellow-brown discoloration of the facial skin, pigment shifts and finally by keratoses, which can lead to cancer precursors and skin cancer, such as spinaliomas and basaliomas.
Es besteht daher nicht nur aus rein ästhetischen Ge-40 sichtspunkten ein Bedarf nach kosmetischen Mitteln, die die schädlichen Nebenwirkungen einer zu langen und intensiven Einwirkung des längerwelligen UV-A-Anteils des Sonnenlichts unterbinden. Die Mittel müssen darüber hinaus toxikologisch und dermatologisch unbedenklich sein, eine gute 45 Licht- und Wärmestabilität aufweisen und gut auf der Haut haften. There is therefore a need, not only from a purely aesthetic point of view, for cosmetic agents which prevent the harmful side effects of too long and intensive exposure to the longer-wave UV-A component of sunlight. The agents must also be toxicologically and dermatologically harmless, have good light and heat stability and adhere well to the skin.
Es wurde nun gefunden, dass ein kosmetisches Lichtschutzmittel mit einem Gehalt an Cyclopentanon- oder Cyclohexanonderivaten der Formel It has now been found that a cosmetic light stabilizer containing cyclopentanone or cyclohexanone derivatives of the formula
O O
ti ti
(I) (I)
0 0
II II
(II) (II)
bzw, respectively,
R-H0^ / R-H0 ^ /
in der n die Zahl 2 oder 3 und R den Rest Ar oder -CH = CH-Ar bedeuten, wobei Ar einen Arylrest, insbesondere einen Phenylrest, der gegebenenfalls durch einen oder mehrere C1-C4-Alkylrest(e), eine oder mehrere Hydroxylgruppe^), eine oder mehrere Ci-C4-Alkoxygruppe(n), eine oder mehrere Amino- oder DHQ-CJ-alkylaminogrup- in which n is the number 2 or 3 and R is the radical Ar or -CH = CH-Ar, where Ar is an aryl radical, in particular a phenyl radical, which may be one or more C1-C4-alkyl radicals, one or more hydroxyl groups ^), one or more Ci-C4-alkoxy group (s), one or more amino or DHQ-CJ-alkylaminogrup-
pe(n), ein oder mehrere Halogenatom(e) oder eine Methylendioxygruppe substituiert ist, darstellt, die gestellten 65 Anforderungen weitgehend erfüllt. pe (n), one or more halogen atom (s) or a methylenedioxy group is substituted, the 65 requirements largely met.
Die Herstellung der im erfindungsgemässen kosmetischen Lichtschutzmittel eingesetzten Cyclopentanon- oder Cyclohexanonderivate kann nach literaturbekannten Ver- The cyclopentanone or cyclohexanone derivatives used in the cosmetic light stabilizer according to the invention can be prepared according to methods known from the literature.
fahren durch Kondensation des entsprechenden cyclischen Ketons mit einem aromatischen Aldehyd unter alkalischen Bedingungen erfolgen. Dabei kann man in der Weise vorgehen, dass man das cyclische Keton und den aromatischen Aldehyd zusammen in einem Lösungsmittel löst und die Lösung mit einer Base versetzt. Man kann aber auch zunächst das cyclische Keton und die Base in ein Lösungsmittel geben und hernach die Mischung mit dem aromatischen Aldehyd versetzen. Die Kondensation der Reaktionsteilnehmer kann dabei bereits bei niedrigen Temperaturen, wie Zimmertemperatur und darunter, erfolgen oder aber auch erst bei höheren Temperaturen durchgeführt werden. Die erforderlichen Reaktionstemperaturen und allgemeinen Reaktionsbedingungen hängen von der chemischen Konstitution der Reaktionsteilnehmer ab und lassen sich leicht ermitteln. drive by condensation of the corresponding cyclic ketone with an aromatic aldehyde under alkaline conditions. This can be done by dissolving the cyclic ketone and aromatic aldehyde together in a solvent and adding a base to the solution. But you can also first put the cyclic ketone and the base in a solvent and then add the aromatic aldehyde to the mixture. The condensation of the reactants can take place at low temperatures, such as room temperature and below, or can only be carried out at higher temperatures. The required reaction temperatures and general reaction conditions depend on the chemical constitution of the reactants and are easy to determine.
Um zu den Cyclopentanon- oder Cyclohexanonderivaten der Formel (II) zu gelangen, wählt man zweckmässig ein Gewichtsverhältnis der Reaktionspartner aromatischer Aldehyd zu cyclischem Keton von 2:1, wobei das cyclische Keton an den der Carbonylgruppe benachbarten Kohlenstoffatomen unsubstituiert sein muss. Wünscht man dagegen ein Cyclopentanon- oder Cyclohexanonderivat der Formel (I) herzustellen, so wird zweckmässig ein Gewichtsverhältnis der Reaktionspartner aromatischer Aldehyd zu cyclischem Keton von 1:1 beziehungsweise ein geringer Überschuss an aromatischem Aldehyd angewandt. Weiterhin ist es im allgemeinen erforderlich, das cyclische Keton so zu modifizieren, dass eine Kondensationsreaktion nur an einem der Carbonylgruppe benachbarten Kohlenstoffatome erfolgen kann, um die Bildung von Nebenprodukten der Formel (II) zu vermeiden. Diese Modifikation kann in der Weise durchgeführt werden, dass man das cyclische Keton mit Morpholin zu einem N-(l-Cycloalkenyl)-morpholin umsetzt. Dieses substituierte Morpholin kann anschliessend mit dem aromatischen Aldehyd kondensiert und hernach das erhaltene Kondensationsprodukt unter sauren Bedingungen zu dem gewünschten Cyclopentanon-bzw. Cyclohexanonderivat der Formel (I) gespalten werden. In order to obtain the cyclopentanone or cyclohexanone derivatives of the formula (II), a weight ratio of the reactants of aromatic aldehyde to cyclic ketone of 2: 1 is expediently chosen, the cyclic ketone having to be unsubstituted on the carbon atoms adjacent to the carbonyl group. If, on the other hand, it is desired to prepare a cyclopentanone or cyclohexanone derivative of the formula (I), a weight ratio of the reactants of aromatic aldehyde to cyclic ketone of 1: 1 or a slight excess of aromatic aldehyde is expediently used. Furthermore, it is generally necessary to modify the cyclic ketone so that a condensation reaction can only take place on one of the carbon atoms adjacent to the carbonyl group in order to avoid the formation of by-products of the formula (II). This modification can be carried out by reacting the cyclic ketone with morpholine to give an N- (l-cycloalkenyl) morpholine. This substituted morpholine can then condense with the aromatic aldehyde and then the condensation product obtained under acidic conditions to the desired cyclopentanone or. Cyclohexanone derivative of the formula (I) are cleaved.
Die bei der Kondensationsreaktion verwendete Base stellt aus wirtschaftlichen Gründen im allgemeinen ein Alkalihydroxid, insbesondere Natriumhydroxid, dar. For economic reasons, the base used in the condensation reaction is generally an alkali hydroxide, in particular sodium hydroxide.
Als Cyclopentanon- bzw. Cyclohexanonderivate, die im erfmdungsgemässen kosmetischen Lichtschutzmittel eingesetzt werden können, sind z.B. 2-Benzylidencyclopentanon, 2-Benzylidencyclohexanon, 2-(4'-Chlorbenzyliden)-cyclo-pentanon, 2-(4'-Methylbenzyliden)-cyclopentanon, 2-(p-Di-methylaminobenzyliden)-cyclopentanon, 2-Anisylidencyclo-pentanon, 2-(p-Hydroxybenzyliden)-cyclopentanon, 2-(3',4'-Dimethoxybenzyliden)-cyclopentanon, 2-(3'-Hydroxy-benzyliden)-cyclopentanon, 2-(3',4'-Diäthylbenzyliden)-cyclopentanon, 2-(4'-Aminobenzyliden)-cyclopentanon, 2-Anisylidencyclohexanon, 2-(4'-Chlorbenzyliden)-cyclo-hexanon, 2-(p-Dimethylaminobenzyliden)-cyclohexanon, 2-(3',4'-Dichlorbenzyliden)-cyclohexanon, 2-(p-Hydroxy-benzyliden)-cyclohexanon, 2-(3',4'-Dibutylbenzyliden)-cyclohexanon, 2,5-Dibenzylidencyclopentanon, 2,5-Bis-(3'-dichlorbenzyliden)-cyclopentanon, 2,5-Dianisylidencyclo-pentanon, 2,5-Disalicylidencyclopentanon, 2,5-Bis-(3'-meth-oxy-4'-hydroxybenzyliden)-cyclopentanon, 2,5-Bis-(p-hy-droxybenzyliden)-cyclopentanon, 2,5-Dipiperonyliden-cyclopentanon, 2,5-Bis-(3',4'-dimethoxy-benzyliden)-cy-clopentanon, 2,5-Dicinnamylidencyclopentanon, 2,6-Bis-(2',3'-dimethoxy-benzyliden)-cyclohexanon, 2,6-Di-benzylidencyclohexanon, 2,6-Dianisylidencyclohexanon, 2,6-Bis-(3',4'-dimethoxybenzyliden)-cyclohexanon, 2,6-Bis-(p-dimethylaminobenzyliden)-cyclohexanon, 2,6-Bis-(4'-iso-butylbenzyliden)-cyclohexanon, 2,6-Bis-(3'-methoxy-4'-hy-droxybenzyliden)-cyclohexanon, 2,6-Bis-(3'-iso-propyl- As cyclopentanone or cyclohexanone derivatives which can be used in the cosmetic light stabilizer according to the invention are, for example 2-benzylidene cyclopentanone, 2-benzylidene cyclohexanone, 2- (4'-chlorobenzylidene) cyclopentanone, 2- (4'-methylbenzylidene) cyclopentanone, 2- (p-dimethylaminobenzylidene) cyclopentanone, 2-anisylidene cyclopentanone, 2- (p-hydroxybenzylidene) cyclopentanone, 2- (3 ', 4'-dimethoxybenzylidene) cyclopentanone, 2- (3'-hydroxybenzylidene) cyclopentanone, 2- (3', 4'-diethylbenzylidene) cyclopentanone , 2- (4'-aminobenzylidene) cyclopentanone, 2-anisylidene cyclohexanone, 2- (4'-chlorobenzylidene) cyclo-hexanone, 2- (p-dimethylaminobenzylidene) cyclohexanone, 2- (3 ', 4'-dichlorobenzylidene) -cyclohexanone, 2- (p-hydroxy-benzylidene) -cyclohexanone, 2- (3 ', 4'-dibutylbenzylidene) -cyclohexanone, 2,5-dibenzylidene cyclopentanone, 2,5-bis- (3'-dichlorobenzylidene) -cyclopentanone, 2,5-dianisylidene cyclopentanone, 2,5-disalicylidene cyclopentanone, 2,5-bis (3'-meth-oxy-4'-hydroxybenzylidene) cyclopentanone, 2,5-bis (p-hy-hydroxybenzylidene) - cyclopentanone, 2,5-dipiperonylidene-cyclopentanone, 2,5-bis- (3 ', 4'-dimethoxy-benzylidene) -cy-clopentanone, 2,5-dicinnamylidene cyclope ntanone, 2,6-bis (2 ', 3'-dimethoxy-benzylidene) cyclohexanone, 2,6-di-benzylidene cyclohexanone, 2,6-dianisylidene cyclohexanone, 2,6-bis (3', 4'-dimethoxybenzylidene ) -cyclohexanone, 2,6-bis- (p-dimethylaminobenzylidene) -cyclohexanone, 2,6-bis- (4'-iso-butylbenzylidene) -cyclohexanone, 2,6-bis- (3'-methoxy-4'- hydroxybenzylidene) cyclohexanone, 2,6-bis (3'-isopropyl)
3 634 986 3,634,986
benzyliden)-cyclohexanon, 2,6-Bis-(p-aminobenzyliden)-cyclohexanon, 2,6-Bis-(4'-äthylaminobenzyliden)-cyclo-hexanon zu nennen. benzylidene) -cyclohexanone, 2,6-bis- (p-aminobenzylidene) -cyclohexanone, 2,6-bis- (4'-ethylaminobenzylidene) -cyclo-hexanone.
Bei ihrem Einsatz in kosmetischen Lichtschutzmitteln s können die beschriebenen Cyclopentanon- bzw. Cyclohexanonderivate in flüssige, pastose oder feste kosmetische Zubereitungen eingearbeitet werden, wie z.B. wässrige Lösungen, wässrige Suspensionen, Emulsionen, Lösungen in organischen Lösungsmitteln, Ölen, Salben, Cremes, Stifte io oder Puder. Bei diesem Einsatz als Lichtschutzmittel gegen die längerwellige UV-A-Strahlung werden die Cyclopentanon- bzw. Cyclohexanonderivate beispielsweise in einem Mengenanteil von 0,5 bis 20 Gew.-%, vorzugsweise 2 bis 10 Gew.-%, bezogen auf den gesamten Ansatz des kosmeti-15 sehen Mittels, verwendet. When used in cosmetic light stabilizers, the cyclopentanone or cyclohexanone derivatives described can be incorporated into liquid, pasty or solid cosmetic preparations, such as aqueous solutions, aqueous suspensions, emulsions, solutions in organic solvents, oils, ointments, creams, sticks io or powder. When used as a light stabilizer against the longer-wave UV-A radiation, the cyclopentanone or cyclohexanone derivatives are used, for example, in a proportion of 0.5 to 20% by weight, preferably 2 to 10% by weight, based on the entire batch of kosmeti-15 see means used.
Neben dem alleinigen Einsatz in kosmetischen Lichtschutzmitteln kann der gemeinsame Einsatz mit üblichen UV-B-Filtersubstanzen, die zur Verhütung des Sonnenbrandes dienen, im Vordergrund der Verwendung stehen. Bei die-20 sem Einsatz können die beschriebenen Cyclopentanon- bzw. Cyclohexanonderivate in Kombination mit üblichen UV-B-Filtersubstanzen, wie zum Beispiel p-Aminobenzoesäure-äthylester, -propylester, -butylester, -isobutylester, -mono-glycerinester, p-Dimethylaminobenzoesäureäthylester, 25 -amylester, p-Diäthylaminobenzoesäureäthylester, -amyl-ester, Salicylsäurementhylester, -homomenthylester, -äthylenglykolester, -glycerinester, -2-äthylhexylester, -tert.butylester, -bornylester, -phenylester, Triäthanol-ammoniumsalz der Salicylsäure, Anthranilsäurementhyl-3o ester, -bornylester, p-Methoxyzimtsäure-3-äthoxyäthylester, -2-äthylhexylester, p-Acetamidozimtsäure-isopropylester, 2,2'-Dihydroxy-4,4'-dimethoxybenzophenon, 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-n-octoxy-benzo-phenon, 4-Phenylbenzophenon, 2-Hydroxy-4-methoxy-35 benzophenon-5-sulfonsäure, 4-Phenyl-benzophenon-2-car-bonsäure-isooctylester, 7-Äthylamino-4-methyl-cumarin, 7,8-Dihydroxycumarin, 6,7-Dihydroxycumarin, 7-Hy-droxyeumarin, 4-Methyl-7-hydroxycumarin, 2-Phenyl-benzimidazol-5-sulfonsäure, Natrium-3,4-dimethoxyphenyl-4o glyoxylat, Butylbenzalaceton, Benzalacetophenon, 3-Ben-zyliden-D,L-campher, 3-(p-Methylbenzyliden)-D,L-cam-pher und Urocaninsäure, eingesetzt werden. In addition to the sole use in cosmetic light stabilizers, the use in common with conventional UV-B filter substances which serve to prevent sunburn can be in the foreground of use. In this application, the cyclopentanone or cyclohexanone derivatives described can be used in combination with conventional UV-B filter substances, such as, for example, ethyl p-aminobenzoate, propyl ester, butyl ester, isobutyl ester, mono-glycerol ester, p-dimethylaminobenzoic acid ethyl ester , 25 -amyl ester, p-diethylaminobenzoic acid ethyl ester, -amyl ester, salicylic acid ethyl ester, -homomenthyl ester, -ethylene glycol ester, -glycerol ester, -2-ethylhexyl ester, -tert.butyl ester, -bornyl ester, -phenyl ester, triethanol-ammonium salt-antioxidant salt of salanic acid ester, -bornyl ester, p-methoxycinnamic acid-3-ethoxyethyl ester, -2-ethylhexyl ester, p-acetamido cinnamic acid isopropyl ester, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy- 4-n-octoxy-benzophenone, 4-phenylbenzophenone, 2-hydroxy-4-methoxy-35-benzophenone-5-sulfonic acid, 4-phenyl-benzophenone-2-car-bonic acid isooctyl ester, 7-ethylamino-4-methyl -coumarin, 7,8-dihydroxycoumarin, 6,7-dihydroxycoumarin, 7-Hy-dr oxyeumarin, 4-methyl-7-hydroxycoumarin, 2-phenyl-benzimidazole-5-sulfonic acid, sodium 3,4-dimethoxyphenyl-4o glyoxylate, butylbenzalacetone, benzalacetophenone, 3-benzylidene-D, L-camphor, 3- ( p-methylbenzylidene) -D, L-cam-pher and urocanic acid can be used.
Die Menge der UV-B-Filtersubstanzen beträgt in diesen auf einer Kombination von UV-A- und UV-B-Schutzsub-45 stanzen basierenden Produkten beispielsweise 1 bis 10 Gew.-%, vorzugsweise 2 bis 6 Gew.-%, bezogen auf das gesamte kosmetische Lichtschutzmittel. The amount of UV-B filter substances in these products based on a combination of UV-A and UV-B protective substances 45 is, for example, 1 to 10% by weight, preferably 2 to 6% by weight, based on the entire cosmetic sunscreen.
Derartige Sonnenschutzmittel verleihen bei topischer Anwendung nicht nur einen wirksamen Schutz gegen den ge-5o fürchteten Sonnenbrand, sondern auch gegen die chronischen Auswirkungen länger dauernder Einflüsse der längerwelligen UV-A-Anteile des Sonnenlichts. When applied topically, such sunscreens not only provide effective protection against the feared sunburn, but also against the chronic effects of longer-lasting effects of the longer-wave UV-A components of sunlight.
Die nachfolgenden Beispiele sollen die schützenden Eigenschaften der beschriebenen Cyclopentanon- bzw. 55 Cyclohexanonderivate sowie deren Eignung für den Einsatz in kosmetischen Lichtschutzmitteln aufzeigen. The following examples are intended to demonstrate the protective properties of the cyclopentanone or 55 cyclohexanone derivatives described and their suitability for use in cosmetic light stabilizers.
Die Herstellung der Cyclopentanon- bzw. Cyclohexanonderivate erfolgte nach literaturbekannten Methoden, wie sie z.B. in der DE-OS 2 245 518 angegeben sind. 6o Nachstehend ist beispielsweise die Herstellung der neuen Verbindung 2,6-Bis-(2',3'-dimethoxybenzyliden)-cyclo-hexanon aufgeführt. The cyclopentanone or cyclohexanone derivatives were prepared by methods known from the literature, such as those e.g. are specified in DE-OS 2 245 518. 6o The preparation of the new compound 2,6-bis- (2 ', 3'-dimethoxybenzylidene) -cyclo-hexanone is listed below, for example.
Herstellung von 2,6-Bis-(2',3'-dimethoxybenzyliden)-cyclo-65 hexanon Preparation of 2,6-bis (2 ', 3'-dimethoxybenzylidene) cyclo-65 hexanone
36,6 g 2,3-Dimethoxybenzaldehyd und 9,8 g Cyclo-hexanon wurden in 200 ml Methanol gelöst. Nach Zugabe einer Lösung von 10 g Ätznatron in 45 ml Wasser wurde die 36.6 g of 2,3-dimethoxybenzaldehyde and 9.8 g of cyclo-hexanone were dissolved in 200 ml of methanol. After adding a solution of 10 g caustic soda in 45 ml water, the
634 986 634 986
4 4th
Mischung unter Rühren 1 Stunde lang auf 35-45 °C gehalten. Dabei schieden sich 39 g eines gelben Kondensationsproduktes aus. Nach Umkristallisation aus Äthanol wurden folgende Analysenwerte erhalten: Mixture kept at 35-45 ° C with stirring for 1 hour. 39 g of a yellow condensation product separated out. After recrystallization from ethanol, the following analytical values were obtained:
% berechnet: C 73,1 H 6,6 0 20,3 % gefunden: C 73,5 H 6,1 0 20,4 % calculated: C 73.1 H 6.6 0 20.3% found: C 73.5 H 6.1 0 20.4
Analog den Angaben der DE-OS 2 245 518 wurden die nachstehenden Verbindungen für die Prüfung in Lichtschutzmitteln hergestellt. In der folgenden Tabelle 1 sind neben der Bezeichnung der Produkte deren Absorptionskennwerte aufgeführt. Analogously to the information in DE-OS 2 245 518, the following compounds were prepared for testing in light stabilizers. In addition to the name of the products, the absorption characteristics are listed in Table 1 below.
Tabelle 1 Table 1
Nr. Produkt 2 max. 1 g Product 2 max. 1 g
(nm) (nm)
1 1
2-Anisyliden-cyclopentanon 2-anisylidene cyclopentanone
327 327
4,2 4.2
2 2nd
2,5-Bis-(3'-methoxy-4'-hydroxybenzyliden)-cyclopentanon 2,5-bis (3'-methoxy-4'-hydroxybenzylidene) cyclopentanone
345 345
4,5 4.5
3 3rd
2-(3',4'-Dimethoxybenzyliden)-cyclopentanon 2- (3 ', 4'-Dimethoxybenzylidene) cyclopentanone
345 345
3,8 3.8
4 4th
2,5-Dibenzyliden-cyclopentanon 2,5-dibenzylidene cyclopentanone
354 354
4,4 4.4
5 5
2,5-Dianisyliden-cyclopentanon 2,5-dianisylidene cyclopentanone
390 390
4,6 4.6
6 6
2,5-Disalicyliden-cyclopentanon 2,5-disalicylidene cyclopentanone
391 391
4,5 4.5
7 7
2-(p-Dimethylaminobenzyliden)-cyclopentanon 2- (p-dimethylaminobenzylidene) cyclopentanone
393 393
4,5 4.5
8 8th
2,5-Bis-(p-hydroxybenzyliden)-cyclopentanon 2,5-bis (p-hydroxybenzylidene) cyclopentanone
397 397
4,3 4.3
9 9
2,5-Dipiperonyliden-cyclopentanon 2,5-dipiperonylidene cyclopentanone
400 400
4,5 4.5
10 10th
2,5-Bis-(3',4'-dimethoxybenzyliden)-cyclopentanon 2,5-bis (3 ', 4'-dimethoxybenzylidene) cyclopentanone
403 403
4,6 4.6
11 11
2,5-Dicinnamyliden-cyclopentanon 2,5-dicinnamylidene cyclopentanone
407 407
4,7 4.7
12 12
2-Anisyliden-cyclohexanon 2-anisylidene cyclohexanone
316 316
4,0 4.0
13 13
2,6-Bis-(2',3'-dimethoxybenzyliden)-cyclohexanon 2,6-bis (2 ', 3'-dimethoxybenzylidene) cyclohexanone
319 319
4,4 4.4
14 14
2,6-Dibenzyliden-cyclohexanon 2,6-dibenzylidene cyclohexanone
327 327
4,4 4.4
15 15
2,6-Dianisyliden-cyclohexanon 2,6-dianisylidene cyclohexanone
358 358
4,4 4.4
16 16
2,6-Bis-(3',4/-dimethoxybenzyliden)-cyclohexanon 2,6-bis (3 ', 4 / -dimethoxybenzylidene) cyclohexanone
372 372
4,4 4.4
17 17th
2-(p-Dimethylaminobenzyliden)-cyclohexanon 2- (p-dimethylaminobenzylidene) cyclohexanone
328 328
4,3 4.3
Nachfolgend werden einige Beispiele für Ausführungsformen des erfindungsgemässen kosmetischen Lichtschutzmittels mit einem Gehalt an Cyclopentanon- bzw. Cyclo-hexanonderivaten aufgeführt: Some examples of embodiments of the cosmetic light stabilizer according to the invention containing cyclopentanone or cyclo-hexanone derivatives are listed below:
Beispiele Examples
1. Zur Herstellung eines Lichtschutzöles werden 80 g 2,5-Dibenzyliden-cyclopentanon unter Erwärmen feinst in 100 g Paraffinöl suspendiert, und danach wird bei ca. 25 °C mit den folgenden weiteren Bestandteilen 1. To produce a light protection oil, 80 g of 2,5-dibenzylidene-cyclopentanone are very finely suspended in 100 g of paraffin oil with heating, and then the following further constituents are added at about 25 ° C.
300 g lecithinhaltiges Pflanzenöl 400 g Olivenöl 100 g Isopropylmyristinat 100 g Purcellinöl innigst vermischt. 300 g vegetable oil containing lecithin 400 g olive oil 100 g isopropyl myristinate 100 g purcellin oil mixed intimately.
2. Zur Herstellung eines Lichtschutzpuders werden 2. To make a sunscreen powder
150 g 2,6-Dibenzyliden-cyclohexanon in einem Pulvermischgerät intensiv mit 350 g Reisstärke 350 g kolloidalem Ton 100 g Lycopodium 100 g Talkum in homogene Verteilung gebracht. 150 g of 2,6-dibenzylidene-cyclohexanone in a powder mixer intensively mixed with 350 g of rice starch, 350 g of colloidal clay, 100 g of lycopodium and 100 g of talc.
3. Zur Herstellung einer Lichtschutzcreme werden 3. To make a sunscreen cream
40 g Glycerinmonostearat 160 g Bienenwachs 420 g Mineralöl 40 g glycerol monostearate 160 g beeswax 420 g mineral oil
50 g Ceresin 50 g of ceresin
50 g einer Absorptionsbase auf Basis von Cholesterin, Bienenwachs, Stearylalkohol und Vaseline 50 g of an absorption base based on cholesterol, beeswax, stearyl alcohol and petroleum jelly
90 g 2-Anisyliden-cyclopentanon bei 65 °C zusammengeschmolzen. In diese warme Mischung wird ein auf die gleiche Temperatur erwärmtes Gemisch von 90 g of 2-anisylidene-cyclopentanone melted together at 65 ° C. In this warm mixture is a mixture heated to the same temperature
247 g Wasser 35 13 g Borax 247 g water 35 13 g borax
2 g p-Oxybenzoesäuremethylester unter starkem Rühren eingearbeitet, und die erhaltene Creme wird bis zum Erreichen der Zimmertemperatur weiter gerührt. 2 g of methyl p-oxybenzoate are incorporated with vigorous stirring, and the cream obtained is stirred further until room temperature is reached.
40 4. Zur Herstellung einer Lichtschutzemulsion wird in ein auf ca. 80 °C erwärmtes Gemisch von 20 g Glycerinmonostearat 70 g Stearinsäure 30 g Ölsäure 4s 20 g Cetylalkohol 40 4. To prepare a light protection emulsion, 70 g stearic acid 30 g oleic acid 4s 20 g cetyl alcohol in a mixture of 20 g glycerol monostearate heated to approx. 80 ° C
80 g 2,6-Dianisyliden-cyclohexanon unter heftigem Rühren eine Mischung von 800 g Wasser 10 g Glycerin so 9 g Triäthanolamin gegeben. Anschliessend wird die erhaltene Lotion kaltgerührt. 80 g of 2,6-dianisylidene-cyclohexanone are added to a mixture of 800 g of water, 10 g of glycerol and 9 g of triethanolamine with vigorous stirring. The lotion obtained is then stirred cold.
Vorstehende Emulsion lässt sich auch unter Mitverwendung eines Treibgases im Vol.-Verhältnis 80 Teile Lotion: 20 ss Teilen Treibgas in Aerosolform verpacken. The above emulsion can also be packaged using a propellant in a volume ratio of 80 parts of lotion: 20 ss parts of propellant in aerosol form.
5. Zur Herstellung eines Sonnenschutzöls werden 5. To make a sunscreen oil
80 g 2-(3',4'-Dimethoxybenzyliden)-cyclopentanon 40 g p-Methoxyzimtsäure-2-äthylhexylester unter Erwärmen feinst in 100 g Paraffinöl suspendiert, und 6o danach wird bei ca. 25 °C mit den folgenden weiteren Bestandteilen 80 g of 2- (3 ', 4'-dimethoxybenzylidene) -cyclopentanone 40 g of 2-ethylhexyl p-methoxycinnamate while heating is very finely suspended in 100 g of paraffin oil, and 6o thereafter at about 25 ° C. with the following further constituents
300 g lecithinhaltiges Pflanzenöl 360 g Olivenöl 100 g Isopropylmyristat 65 100 g Purcellinöl innigst vermischt. 300 g vegetable oil containing lecithin 360 g olive oil 100 g isopropyl myristate 65 100 g purcellin oil mixed intimately.
6. Zur Herstellung einer Sonnenschutzcreme werden 6. To make a sunscreen
40 g Glycerinmonostearat 40 g glycerol monostearate
5 5
634 986 634 986
150 g Bienen wachs 390 g Mineralöl 50 g Ceresin 150 g beeswax 390 g mineral oil 50 g ceresin
50 g einer Absorptionsbase auf Basis von Cholesterin, Bienenwachs, Stearylalkohol und Vaseline 50 g of an absorption base based on cholesterol, beeswax, stearyl alcohol and petroleum jelly
90 g 2,5-Bis-(3'-methoxy-4'-hydroxybenzyliden)- 90 g 2,5-bis (3'-methoxy-4'-hydroxybenzylidene) -
cyclopentanon 40 g 3-(p-Methylbenzyliden)-D,L-campher bei 65 °C zusammengeschmolzen. In diese warme Mischung wird ein auf die gleiche Temperatur erwärmtes Gemisch von 247 g Wasser 13 g Borax cyclopentanone 40 g of 3- (p-methylbenzylidene) -D, L-camphor melted together at 65 ° C. A mixture of 247 g of water and 13 g of borax heated to the same temperature is added to this warm mixture
2 g p-Oxybenzoesäuremethylester unter starkem Rühren'eingearbeitet, und die erhaltene Creme wird bis zum Erreichen der Zimmertemperatur weiter gerührt. 2 g of methyl p-oxybenzoate are incorporated with vigorous stirring, and the cream obtained is stirred further until room temperature is reached.
7. Zur Herstellung einer Sonnenschutzemulsion wird in ein auf ca. 80 °C erwärmtes Gemisch von 20 g Glycerinmonostearat 70 g Stearinsäure 30 g Ölsäure 7. To prepare a sunscreen emulsion, 70 g of stearic acid and 30 g of oleic acid are added to a mixture of 20 g of glycerol monostearate heated to approximately 80 ° C.
20 g Cetylalkohol 20 g cetyl alcohol
80 g 2,6-Bis-(3',4'-dimethoxybenzyliden)-cyclohexa-non 80 g 2,6-bis (3 ', 4'-dimethoxybenzylidene) cyclohexa-non
40 g p-Dimethylaminobenzoesäure-2-äthylhexyl-5 ester unter heftigem Rühren eine Mischung von 800 g Wasser 40 g p-dimethylaminobenzoic acid 2-ethylhexyl 5-ester with vigorous stirring a mixture of 800 g water
10 g Glycerin 9 g Triäthanolamin io gegeben. Anschliessend wird die erhaltene Lotion kaltgerührt. 10 g glycerol 9 g triethanolamine io given. The lotion obtained is then stirred cold.
Vorstehende Emulsion lässt sich auch unter Mitverwendung eines Treibgases im Vol.-Verhältnis 80 Teile Lotion: 20 Teilen Treibgas in Aerosolform verpacken. The above emulsion can also be packaged using a propellant in a volume ratio of 80 parts lotion: 20 parts propellant in aerosol form.
Anstelle der in den vorgenannten Rezepturen eingesetzten Cyclopentanon- bzw. Cyclohexanonderivate können auch die anderen vorstehend aufgeführten Cyclopentanon-bzw. Cyclohexanonderivate verwendet werden, und an die 20 Stelle der in den Rezepturen genannten UV-B-Filtersubstan-zen können auch die anderen aufgeführten UV-B-Filtersub-stanzen treten. Instead of the cyclopentanone or cyclohexanone derivatives used in the aforementioned formulations, the other cyclopentanone or. Cyclohexanone derivatives are used, and the 20 UV-B filter substances listed in the recipes can also be substituted for the other UV-B filter substances listed.
s s
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19772728241 DE2728241A1 (en) | 1977-06-23 | 1977-06-23 | COSMETIC LIGHT PROTECTION AGENTS FOR THE UV-A AREA |
Publications (1)
Publication Number | Publication Date |
---|---|
CH634986A5 true CH634986A5 (en) | 1983-03-15 |
Family
ID=6012158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH688978A CH634986A5 (en) | 1977-06-23 | 1978-06-23 | Cosmetic light-stabilising agent for the UV-A region |
Country Status (7)
Country | Link |
---|---|
AT (1) | AT355218B (en) |
BE (1) | BE868397A (en) |
CH (1) | CH634986A5 (en) |
DE (1) | DE2728241A1 (en) |
FR (1) | FR2395023A1 (en) |
IT (1) | IT1097258B (en) |
NL (1) | NL7806034A (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU83912A1 (en) * | 1982-01-29 | 1983-09-02 | Oreal | APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS |
US4514383A (en) * | 1982-05-05 | 1985-04-30 | Johnson & Johnson Baby Products Company | Sunscreen compositions containing vinylogous amides |
JPS60109544A (en) * | 1983-11-17 | 1985-06-15 | Kao Corp | Novel chalcone derivative and ultraviolet light absorber containing it |
LU87030A1 (en) * | 1987-10-28 | 1989-05-08 | Oreal | USE IN COSMETICS OF NEW SUBSTANCES AS INFRARED RADIATION REFLECTORS, COSMETIC COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE PROTECTION OF THE HUMAN SKIN AGAINST INFRARED RADIATION |
LU87339A1 (en) * | 1988-09-20 | 1990-04-06 | Oreal | NOVEL BENZYLIDENE-CYCLANONES DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS ANTI-OXIDIZING AGENTS AND AS SOLAR FILTERS, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2638354B1 (en) * | 1988-10-28 | 1993-10-15 | Oreal | FILTERING COSMETIC COMPOSITIONS, THEIR USE FOR PROTECTING THE SKIN AND HAIR AGAINST ULTRAVIOLET RADIATION, NOVEL 5-BENZYLIDENE 3-OXA CYCLOPENTANONE DERIVATIVES USED IN SUCH COMPOSITIONS AND THEIR PREPARATION PROCESS |
FR2645145B1 (en) * | 1989-03-31 | 1991-07-19 | Oreal | COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING LIPOPHILIC DERIVATIVES OF BENZYLIDENE CAMPHOR AND NOVEL LIPOPHILIC DERIVATIVES OF BENZYLIDENE CAMPHER |
ID17907A (en) * | 1997-02-20 | 1998-02-05 | Fakultas Farmasi Uni Gajah Mad | BENZILIDIN CYCYLOHEXANON BENZILIDINE CYCOPOPANANONE BINZYLIDINE ACETONE AND ITS PRODUCTION |
FR2833164B1 (en) | 2001-12-07 | 2004-07-16 | Oreal | ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGISTIC MIXTURE OF FILTERS AND USES |
JP6100896B2 (en) | 2012-07-13 | 2017-03-22 | ロレアル | Composite pigment and preparation method thereof |
JP6096898B2 (en) | 2012-07-13 | 2017-03-15 | ロレアル | Cosmetic composition |
FR2993176B1 (en) | 2012-07-13 | 2014-06-27 | Oreal | COSMETIC COMPOSITION CONTAINING MEDIUM SIZE FILTERING PARTICLES UP TO 0.1 MICRON AND INORGANIC FILTER PARTICLES AND AQUEOUS PHASE |
WO2014010101A1 (en) | 2012-07-13 | 2014-01-16 | L'oreal | Composite pigment and method for preparing the same |
US20150157539A1 (en) | 2012-07-13 | 2015-06-11 | L'oreal | Cosmetic composition comprising composite particles |
WO2014111566A2 (en) | 2013-01-21 | 2014-07-24 | L'oreal | Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent |
WO2016030839A1 (en) | 2014-08-28 | 2016-03-03 | L'oreal | Gel composition and gel comprising a uv filter |
EP3223777A1 (en) | 2014-11-24 | 2017-10-04 | L'Oréal | Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter |
FR3037243B1 (en) | 2015-06-11 | 2018-11-16 | L'oreal | COMPOSITION COMPRISING UV FILTER, ANIONIC CROSSLINKABLE HYDROPHILIC POLYMER, SURFACTANT HAVING HLB LESS THAN OR EQUAL TO 5 AND SILICONE COPOLYMER |
FR3073408B1 (en) | 2017-11-15 | 2019-10-11 | L'oreal | COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC FILTER |
FR3083093A1 (en) | 2018-06-28 | 2020-01-03 | L'oreal | PHOTOPROTECTOR COMPOSITION COMPRISING COLLOIDAL SILICA PARTICLES |
FR3090329B1 (en) | 2018-12-21 | 2020-12-04 | Oreal | Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane |
FR3103705B1 (en) | 2019-11-29 | 2021-12-17 | Oreal | A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil |
FR3103704B1 (en) | 2019-11-29 | 2022-07-08 | Oreal | Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH380882A (en) * | 1959-02-10 | 1964-08-14 | Givaudan & Cie Sa | Use of fluorene derivatives as protective agents against ultraviolet radiation |
DE2051824C3 (en) * | 1970-10-22 | 1975-11-27 | Merck Patent Gmbh, 6100 Darmstadt | Cosmetic light protection agent |
LU67061A1 (en) * | 1973-02-19 | 1974-09-25 | ||
DE2365772A1 (en) * | 1973-07-17 | 1976-04-15 | Merck Patent Gmbh | UV absorbing camphor derivs - for use as cosmetic sun-screen agents |
DE2336219A1 (en) * | 1973-07-17 | 1975-02-20 | Merck Patent Gmbh | CAMPHERDER DERIVATIVES |
FR2282426A2 (en) * | 1974-08-19 | 1976-03-19 | Oreal | Bornylidene benzene sulphonic acid dervs - as ultra-violet absorbing agents prepd. by sulphonation |
-
1977
- 1977-06-23 DE DE19772728241 patent/DE2728241A1/en not_active Withdrawn
-
1978
- 1978-06-02 NL NL7806034A patent/NL7806034A/en not_active Application Discontinuation
- 1978-06-20 IT IT24727/78A patent/IT1097258B/en active
- 1978-06-22 AT AT454978A patent/AT355218B/en not_active IP Right Cessation
- 1978-06-23 FR FR7818888A patent/FR2395023A1/en not_active Withdrawn
- 1978-06-23 CH CH688978A patent/CH634986A5/en not_active IP Right Cessation
- 1978-06-23 BE BE188796A patent/BE868397A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BE868397A (en) | 1978-12-27 |
IT1097258B (en) | 1985-08-31 |
AT355218B (en) | 1980-02-25 |
FR2395023A1 (en) | 1979-01-19 |
DE2728241A1 (en) | 1979-01-11 |
IT7824727A0 (en) | 1978-06-20 |
ATA454978A (en) | 1979-07-15 |
NL7806034A (en) | 1978-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH634986A5 (en) | Cosmetic light-stabilising agent for the UV-A region | |
DE2544180C2 (en) | Light protection preparations for cosmetic purposes | |
EP0693471B1 (en) | Benzylidene-norcamphor derivatives | |
AT400399B (en) | LIGHT-STABLE COSMETIC AGENT FOR PROTECTING HUMANEPIDERMIS FROM UV RAYS AND METHOD FOR STABILIZING 4- (1,1 DIMETHYLETHYL) -4'-METHOXYDIBENZOYLMETHANE FROM UV RADIATION | |
DE3441636C2 (en) | Ultraviolet absorber containing new chalcone derivatives | |
EP0694521B1 (en) | Ketotricyclo(5.2.1.0)decane derivatives | |
DE69100593T2 (en) | LIGHT-RESISTANT FILTERING COSMETIC COMPOSITION CONTAINING A UVA FILTER AND A BETA-BETA-DIPHENYLACRYLATE OR AN ALPHA-CYANO-BETA-BETA-DIPHENYLACRYLIC ACID ALKYL ESTER. | |
DE3321679A1 (en) | 3-BENZYLIDE-CAMPHER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF FOR PROTECTION AGAINST UV RADIATION, AND MEANS THAT CONTAIN THEM | |
DE2816819A1 (en) | LIGHT PROTECTION AGENTS | |
DE1201953B (en) | Use of new 2-phenyl-benzoxazoles as a protective agent for human skin against ultraviolet radiation | |
DE3731858A1 (en) | LIGHT-RESISTANT COSMETIC AGENT, WHICH CONTAINS TRIHYDROXYETHYLRUTIN IN COMBINATION WITH WATER-SOLUBLE FILTERS DERIVED BY BENZYLIDE FIGHTER, AND THE USE THEREOF TO PROTECT THE SKIN AND HAIR | |
CH626803A5 (en) | ||
EP0486885B1 (en) | Utilization of arylpolyencarboxylic acids and their derivatives as light protection agents in cosmetic compositions | |
DE2347928A1 (en) | PROTECTIVE AGENTS AGAINST ACTINIC RADIATIONS AND AGENTS CONTAINING THEM | |
DE4221740A1 (en) | Benzylidene quinuclidinones | |
DE19508608A1 (en) | Cosmetic sunscreen compsns. contg. UV-A filters | |
EP0474063B1 (en) | Dialkoxybenzylidene campher derivatives | |
CH634987A5 (en) | Cosmetic light-stabilising agent for the UV-A region | |
DE3543496A1 (en) | 4-METHOXY-2'-CARBOXYDIBENZOYLMETHANE AND ITS SALTS | |
DE3519926A1 (en) | INDOLINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND COSMETIC LIGHT PROTECTION AGENTS CONTAINING THESE INDOLINE DERIVATIVES | |
CH634988A5 (en) | Cosmetic light-stabilising agent for the UV-A region | |
EP0581954B1 (en) | Use of alpha-hydroxyketoalkyl derivatives as protective light filters | |
JPH022871B2 (en) | ||
EP0582711B1 (en) | Ketotricyclo(5.2.1.0)decane derivates | |
DE3843325C2 (en) | Unsaturated 3-benzylidene-camphor derivatives, processes for their preparation, cosmetic products containing these compounds and processes for protecting the skin and for protecting a cosmetic product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |